Biogen Inc. Price Today
Biogen Inc.
BIIB
Healthcare
$33.96B
💰
Market Cap
12.8
💸
Price to Earnings
$18.3
🎉
EPS
+79
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
20 |
Strong Buy |
11 |
Hold |
10 |
Sell |
0 |
Strong Sell |
0 |
BIIB Price Forecast Target
234.5 👉 500.0 +113%
BIIB EPS Forecast
18.3 👉 16.6 +-10%
Financials
Profit Margin
27 %
Revenue Growth
-5.1 %
Dividend
$ 0
Held Percent
0.7% - Insiders
90.9% - Institutions
8.4% - Public
Major Fund Holders
-
💰 Primecap Management Company $3.8B
-
💰 Blackrock Inc. $3.3B
-
💰 Vanguard Group Inc $2.9B
-
💰 State Street Corporation $1.6B
-
💰 Wellington Management Group, LLP $1.3B
Stock Ideas
Ken Fisher Portfolio
Ken Fisher is a prominent American investment analyst, author, and the founder of Fisher Investments, a global investment firm managing billions of dollars in assets for individual and institutional clients. As a highly successful investor and fina…
Israel Englander Portfolio
Israel Englander, a notable figure in the finance industry, began his journey by obtaining his undergraduate degree from NYU before venturing into trading on the American Stock Exchange (AMEX), where he found early success. In 1989, he went on to es…
Jim Chanos Portfolio
Jim Chanos is a revered figure in the world of portfolio management, known for his expertise in short selling and his pivotal role in uncovering fraud at Enron and WorldCom. Hailing from Milwaukee and a graduate of Yale with an economics degree, Ch…
Nelson Peltz Portfolio
Nelson Peltz is a renowned investor known for his astute investment strategies and activist approach. With a portfolio spanning diverse industries, Peltz strategically targets underperforming companies, advocating for changes that unlock their full …📮FAQ
Some Frequently Asked Questions.
The Biogen Inc. industry is Drug Manufacturers - General
The Biogen Inc. sector is Healthcare
The Biogen Inc. forecasted predicted Price to Earnings PE ratio is 14.2
The Biogen Inc. Price to Earnings PE ratio is 12.8
The Market Capitalization of Biogen Inc. is $33.96B
There are total of 144388865 float shares with 90.9% held by Institutions and 0.7% held by insiders
The MBiogen Inc. forecasted Earnings per Share EPS is $16.6
The Biogen Inc. Earnings per Share EPS is 18.3
The Biogen Inc. company has $7895100000 gross profits with 27 profit margins
The Biogen Inc. Earnings Growth is -0.438% with -0.441% quarterly earnings growth
The Biogen Inc. Revenue is $9971500032 with -0.051 revenue growth
The price target for Biogen Inc. stock is $500.0 for the high target and $269.0 for the low target
The consensus analyst recommendations for Biogen Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Biogen Inc. is Buy, with the following breakdown:
- Buy: 20
- Strong Buy: 11
- Hold: 10
- Sell: 0
- Strong Sell: 0
The Beta of Biogen Inc. is 0.1
The dividend of Biogen Inc. is $0
The dividend yield of Biogen Inc. is 0.037100002%
The biggest institutional and mutual fund holders of Biogen Inc. stock are
- Primecap Management Company
- Blackrock Inc.
- Vanguard Group Inc
- State Street Corporation
The Biogen Inc. ESG Score is 79, with the following breakdown:
- E: 0.02
- S: 13.22
- G: 7.81